A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty

Division of Cardiology, Department of Internal Medicine, William Beaumont Hospital, Royal Oak, Michigan 48073-6769, USA.

OBJECTIVES: The purpose of this study was to determine prospectively whether the differences in anticoagulant and antiplatelet effects of ionic and nonionic contrast media after angiographic or clinical outcomes in patients with unstable ischemic syndromes undergoing percutaneous transluminal coronary angioplasty. BACKGROUND: The interaction of platelets and thrombin with the endothelium of injured vessels contributes to thrombosis and restenosis after coronary angioplasty. Case reports and retrospective observations have reported an increased risk of thrombosis with the use of nonionic contrast media. METHODS: A total of 211 patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty were randomized to receive nonionic or ionic low osmolar contrast media. Coronary angiograms were assessed by a technician blinded to the study contrast media, and clinical events were monitored by an independent nurse for 1 month. RESULTS: Patients receiving the ionic media were significantly less likely to experience decreased blood flow during the procedure (8.1% vs. 17.8%, p = 0.04). After the angioplasty, residual stenosis, vessel patency, the incidence of moderate to large thrombi and use of adjunctive thrombolytic therapy were similar between the two groups. However, patients receiving ionic media had fewer recurrent ischemic events requiring repeat catheterization (3.0% vs. 11.4%, p = 0.02) and repeat angioplasty during the initial hospital stay (1.0% vs. 5.8%, p = 0.06). One month after angioplasty, patients receiving ionic contrast media reported significantly fewer symptoms of any angina (8.5 vs. 20.0%, p = 0.04) or of angina at rest (1.4% vs. 11.8%, p = 0.01) and a reduced need for subsequent bypass surgery (0% vs. 5.9%, p = 0.04), compared with patients receiving the nonionic media. CONCLUSIONS: These findings demonstrate that in patients with unstable ischemic syndromes undergoing coronary angioplasty, the use of ionic low osmolar contrast media reduces the risk of ischemic complications acutely and at 1 month after the procedure. Therefore, low osmolar ionic contrast media should be strongly considered when performing interventions in patients with unstable angina or myocardial infarction.

This article has been cited by other articles:

				C. Mueller, G. Buerkle, H. J. Buettner, J. Petersen, A. P. Perruchoud, U. Eriksson, S. Marsch, and H. Roskamm Prevention of Contrast Media-Associated Nephropathy: Randomized Comparison of 2 Hydration Regimens in 1620 Patients Undergoing Coronary Angioplasty Arch Intern Med, February 11, 2002; 162(3): 329 - 336. [Abstract] [Full Text] [PDF]

				B. Scheller A reply Eur. Heart J., January 2, 2002; 23(2): 173 - 175. [Full Text] [PDF]

				V. Legrand Ionic or non-ionic contrast during coronary intervention: does it make a difference? Eur. Heart J., March 1, 2001; 22(5): 353 - 354. [PDF]

				B Scheller, B Hennen, A Pohl, H Schieffer, and T Markwirth Acute and subacute stent occlusion; risk-reduction by ionic contrast media Eur. Heart J., March 1, 2001; 22(5): 385 - 391. [Abstract] [PDF]

				C. J. Davidson, W. K. Laskey, J. B. Hermiller, J. K. Harrison, W. Matthai Jr, R. E. Vlietstra, J. A. Brinker, D. J. Kereiakes, J. B. Muhlestein, A. Lansky, et al. Randomized Trial of Contrast Media Utilization in High-Risk PTCA : The COURT Trial Circulation, May 9, 2000; 101(18): 2172 - 2177. [Abstract] [Full Text] [PDF]

				T. Matsubara, S. Minatoguchi, H. Matsuo, K. Hayakawa, T. Segawa, Y. Matsuno, S. Watanabe, M. Arai, Y. Uno, M. Kawasaki, et al. Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease J. Am. Coll. Cardiol., February 1, 2000; 35(2): 345 - 351. [Abstract] [Full Text] [PDF]

				M. E. Bertrand, E. Esplugas, J. Piessens, and W. Rasch Influence of a Nonionic, Iso-Osmolar Contrast Medium (Iodixanol) Versus an Ionic, Low-Osmolar Contrast Medium (Ioxaglate) on Major Adverse Cardiac Events in Patients Undergoing Percutaneous Transluminal Coronary Angioplasty : A Multicenter, Randomized, Double-Blind Study Circulation, January 18, 2000; 101(2): 131 - 136. [Abstract] [Full Text] [PDF]

				W. H. Matthai Jr., P. B. Kurnik, W. C. Groh, W. J. Untereker, and J. E. Siegel Antithrombin activity during the period of percutaneous coronary revascularization: Relation to heparin use, thrombotic complications and restenosis J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1248 - 1256. [Abstract] [Full Text] [PDF]

				T. P. Wharton Jr., N. S. McNamara, F. A. Fedele, M. I. Jacobs, A. R. Gladstone, and E. J. Funk Primary angioplasty for the treatment of acute myocardial infarction: experience at two community hospitals without cardiac surgery J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1257 - 1265. [Abstract] [Full Text] [PDF]

				R. Schrader, I. Esch, R. Ensslen, W. A. Fach, H. Merle, D. Scherer, H. Sievert, H. F. Spies, and H. E. Zeplin A randomized trial comparing the impact of a nonionic (iomeprol) versus an ionic (ioxaglate) low osmolar contrast medium on abrupt vessel closure and ischemic complications after coronary angioplasty J. Am. Coll. Cardiol., February 1, 1999; 33(2): 395 - 402. [Abstract] [Full Text] [PDF]

				N. R. Every, L. S. Parsons, M. Hlatky, J. S. Martin, W. D. Weaver, and The Myocardial Infarction Triage and Intervention A Comparison of Thrombolytic Therapy with Primary Coronary Angioplasty for Acute Myocardial Infarction N. Engl. J. Med., October 24, 1996; 335(17): 1253 - 1260. [Abstract] [Full Text] [PDF]